18715216

Source:http://linkedlifedata.com/resource/pubmed/id/18715216

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011854, umls-concept:C0017725, umls-concept:C0035647, umls-concept:C0332281, umls-concept:C0392756, umls-concept:C0537551, umls-concept:C2827666
pubmed:issue	5
pubmed:dateCreated	2008-8-21
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00107107
pubmed:abstractText	This study was designed to determine whether pramlintide added to insulin therapy reduced the risks associated with extreme blood glucose (BG) fluctuations in patients with type 1 diabetes.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/R01 DK 51562
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100889084
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Amyloid, http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Islet Amyloid Polypeptide, http://linkedlifedata.com/resource/pubmed/chemical/pramlintide
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1520-9156
pubmed:author	pubmed-author:CreanJohnJ, pubmed-author:KovatchevBoris PBP, pubmed-author:McCallAnthonyA
pubmed:issnType	Print
pubmed:volume	10
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	391-6
pubmed:dateRevised	2011-3-1
pubmed:meshHeading	pubmed-meshheading:18715216-Adult, pubmed-meshheading:18715216-Amyloid, pubmed-meshheading:18715216-Blood Glucose, pubmed-meshheading:18715216-Databases, Factual, pubmed-meshheading:18715216-Diabetes Mellitus, Type 1, pubmed-meshheading:18715216-Double-Blind Method, pubmed-meshheading:18715216-Female, pubmed-meshheading:18715216-Humans, pubmed-meshheading:18715216-Hyperglycemia, pubmed-meshheading:18715216-Hypoglycemia, pubmed-meshheading:18715216-Hypoglycemic Agents, pubmed-meshheading:18715216-Islet Amyloid Polypeptide, pubmed-meshheading:18715216-Male, pubmed-meshheading:18715216-Middle Aged, pubmed-meshheading:18715216-Postprandial Period, pubmed-meshheading:18715216-Randomized Controlled Trials as Topic, pubmed-meshheading:18715216-Retrospective Studies, pubmed-meshheading:18715216-Risk Factors
pubmed:year	2008
pubmed:articleTitle	Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.
pubmed:affiliation	University of Virginia Health System, Charlottesville, Virginia 22901, USA. boris@virginia.edu
pubmed:publicationType	Journal Article, Research Support, N.I.H., Extramural